NOBBIO, LUCILLA
 Distribuzione geografica
Continente #
EU - Europa 8.011
AS - Asia 964
NA - Nord America 870
Continente sconosciuto - Info sul continente non disponibili 86
SA - Sud America 76
AF - Africa 13
OC - Oceania 1
Totale 10.021
Nazione #
IT - Italia 7.865
US - Stati Uniti d'America 801
SG - Singapore 384
CN - Cina 230
VN - Vietnam 171
BD - Bangladesh 70
FR - Francia 65
HK - Hong Kong 40
BR - Brasile 37
CA - Canada 27
AR - Argentina 15
MX - Messico 15
JP - Giappone 14
DE - Germania 12
CO - Colombia 11
FI - Finlandia 10
ID - Indonesia 9
IN - India 9
JM - Giamaica 9
NL - Olanda 9
CH - Svizzera 8
IQ - Iraq 7
GB - Regno Unito 6
BE - Belgio 5
ES - Italia 5
GT - Guatemala 4
MY - Malesia 4
VE - Venezuela 4
ZA - Sudafrica 4
AT - Austria 3
CL - Cile 3
EC - Ecuador 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
PL - Polonia 3
PR - Porto Rico 3
SA - Arabia Saudita 3
CR - Costa Rica 2
EG - Egitto 2
GR - Grecia 2
IE - Irlanda 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
PK - Pakistan 2
PT - Portogallo 2
RU - Federazione Russa 2
SE - Svezia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.935
Città #
Genova 4.255
Genoa 2.163
Rapallo 762
Vado Ligure 553
San Jose 220
Singapore 193
Ashburn 67
Lauterbourg 54
Hanoi 49
Ho Chi Minh City 46
Hong Kong 38
New York 37
Beijing 31
Rome 24
Santa Clara 24
Milan 21
Los Angeles 18
Bordighera 17
Council Bluffs 15
Tokyo 13
Chicago 12
Helsinki 10
Biên Hòa 9
San Francisco 9
Buffalo 8
Frankfurt am Main 8
Mexico City 8
Dallas 7
Houston 7
Montreal 7
Turin 7
Zurich 7
Baghdad 6
Da Nang 6
Haiphong 6
Kingston 6
Phoenix 6
Toronto 6
Amsterdam 5
Atlanta 5
Bologna 5
Orem 5
Salt Lake City 5
São Paulo 5
Augusta 4
Guangzhou 4
Guatemala City 4
Paris 4
Athens 3
Brooklyn 3
Bắc Ninh 3
Cali 3
Can Tho 3
Changsha 3
Dhaka 3
Eugene 3
Greenville 3
Johannesburg 3
Las Vegas 3
Memphis 3
Naples 3
Nashville 3
Padua 3
Philadelphia 3
Portland 3
Riga 3
Shanghai 3
Shenzhen 3
Vĩnh Tường 3
Warsaw 3
Wilmington 3
Abilene 2
Albuquerque 2
Anchorage 2
Anderlecht 2
Arroyo Grande 2
Brussels 2
Calgary 2
Chanhassen 2
Charlotte 2
Chennai 2
City of London 2
Cleveland 2
Columbia 2
Columbus 2
Da Lat 2
Dammam 2
Des Moines 2
Dublin 2
Durham 2
Edmonton 2
Fortaleza 2
Georgetown 2
Havertown 2
Jaipur 2
Jakarta 2
Kalkaska 2
Kathmandu 2
Lahore 2
León 2
Totale 8.908
Nome #
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 225
Does parkin play a role in the peripheral nervous system? A family report 218
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 215
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 207
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 204
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 199
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 193
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 192
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 191
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 190
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 189
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 187
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 186
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 185
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 180
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 178
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 175
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 174
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 167
Correlation among demyelination and axonal degeneration: a new trophic role for myelin sheath 167
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 165
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 159
Mifepristone (RU 38486) influences expression of glycoprotein Po and morphological parameters at the level of rat sciatic nerve: In vivo observations . 158
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 158
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 158
Inherited Peripheral Neuropathies 154
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 153
Oxydative phosphorilation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 152
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. 152
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 148
Ebf Genes In Peripheral Nerve Myelination 147
P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy 147
Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 145
P2X7 antagonism in experimental CMT1A: a potential therapeutic strategy 145
Synaptopodin and 4 novel genes identified in primary sensory neurons. 143
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 141
PMP22 messenger RNA levels in skin biopsies: Testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker 139
The transcription factors EBF1 and EBF2 are positive regulators of myelination in Schwann cells 139
Ebf genes' silencing impairs myelin formation 137
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 135
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 134
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 133
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 130
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 129
Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy. 129
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial. 126
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 126
Energetic disfunction in CMT1A: role of myelin and neuron mitochondria 125
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 125
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 123
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neuropathy. 121
Energetic metabolism of myelinated axons: a new correlation among axonal degeneration, demyelination and energy supply. 120
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 (PMP22) 120
Energy supply and demyelinising diseases: a new trophic role of myelin sheath. 119
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neurophaty. 118
Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations 118
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 115
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 114
Functional Characterization of Hyccin, a Novel Membrane Protein Involved in Central and Peripheral Myelination 114
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 106
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 104
Increased [18F]DPA-714 Uptake in the Skeletal Muscle of SOD1G93A Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis 101
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 99
Neuropatie di Charcot-Marie-Tooth: dalla patologia alla patogenesi 85
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 79
Inherited neuropathies. 77
Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders? 71
Basic Pathological Mechanisms in Peripheral Nerve Diseases 50
null 48
Techniques for the standard histological and ultrastructural assessment of nerve biopsies 39
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients 26
Totale 10.021
Categoria #
all - tutte 32.504
article - articoli 25.107
book - libri 0
conference - conferenze 6.932
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 465
Totale 65.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022671 0 0 51 86 20 48 44 186 32 63 31 110
2022/2023885 74 82 7 83 173 132 2 81 139 6 94 12
2023/2024494 31 51 15 63 36 85 58 39 22 10 23 61
2024/20251.426 96 83 52 104 167 126 111 272 53 48 154 160
2025/20262.470 372 71 133 160 422 176 359 110 150 239 123 155
2026/2027420 201 91 128 0 0 0 0 0 0 0 0 0
Totale 10.021